Reynders McVeigh Capital Management, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,284 filers reported holding NOVARTIS A G in Q2 2024. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.

Quarter-by-quarter ownership
Reynders McVeigh Capital Management, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q2 2024$12,173
+3.8%
114,342
-5.7%
0.69%
+2.4%
Q1 2024$11,726
-7.2%
121,220
-3.1%
0.68%
-15.6%
Q4 2023$12,632
-2.0%
125,105
-1.1%
0.80%
-9.7%
Q3 2023$12,888
-0.6%
126,524
-1.6%
0.89%
+4.2%
Q2 2023$12,971
+6.0%
128,536
-3.4%
0.85%
+1.0%
Q1 2023$12,241
-4.1%
133,051
-5.5%
0.84%
-10.2%
Q4 2022$12,769
-99.9%
140,755
+0.8%
0.94%
+13.8%
Q3 2022$10,612,000
-8.5%
139,608
+1.7%
0.82%
-5.3%
Q2 2022$11,599,000
+3.1%
137,221
+7.0%
0.87%
+26.5%
Q1 2022$11,252,000
-0.7%
128,224
-1.1%
0.69%
+7.0%
Q4 2021$11,337,000
+7.2%
129,615
+0.2%
0.64%
-0.8%
Q3 2021$10,578,000
-10.8%
129,351
-0.5%
0.65%
-10.9%
Q2 2021$11,860,000
-14.5%
129,981
-19.9%
0.73%
-21.4%
Q1 2021$13,877,000
-24.6%
162,347
-16.7%
0.92%
-26.5%
Q4 2020$18,408,000
+5.7%
194,942
-2.6%
1.26%
-6.3%
Q3 2020$17,408,000
-3.7%
200,182
-3.2%
1.34%
-15.1%
Q2 2020$18,069,000
-9.7%
206,887
-14.7%
1.58%
-30.6%
Q1 2020$20,002,000
-16.6%
242,591
-4.2%
2.28%
-1.4%
Q4 2019$23,980,000
+6.1%
253,252
-2.6%
2.31%
-4.2%
Q3 2019$22,602,000
-11.0%
260,092
-6.5%
2.41%
-11.4%
Q2 2019$25,406,000
-11.3%
278,238
-6.6%
2.72%
-14.0%
Q1 2019$28,634,000
+12.4%
297,841
+0.3%
3.17%
-6.3%
Q4 2018$25,479,000
-0.5%
296,918
-0.1%
3.38%
+12.3%
Q3 2018$25,619,000
+14.6%
297,345
+0.4%
3.01%
+5.5%
Q2 2018$22,362,000
-16.6%
296,030
-10.7%
2.85%
-15.9%
Q1 2018$26,806,000
+8.6%
331,552
+12.8%
3.39%
+4.8%
Q4 2017$24,677,000
-6.2%
293,915
-4.1%
3.23%
-5.7%
Q3 2017$26,312,000
+6.3%
306,484
+3.3%
3.43%
+3.5%
Q2 2017$24,757,000
+12.3%
296,595
-0.1%
3.31%
+9.5%
Q1 2017$22,040,000
-3.8%
296,756
-5.6%
3.03%
-6.9%
Q4 2016$22,906,000
-6.3%
314,474
+1.5%
3.25%
-8.7%
Q3 2016$24,458,000
-4.0%
309,751
+0.3%
3.56%
-3.7%
Q2 2016$25,487,000
+26.8%
308,894
+11.3%
3.70%
+24.3%
Q1 2016$20,105,000
-8.9%
277,537
+8.2%
2.98%
-17.7%
Q4 2015$22,063,000
-1.6%
256,423
+5.1%
3.62%
-7.4%
Q3 2015$22,429,000
-3.3%
244,002
+3.4%
3.91%
+3.1%
Q2 2015$23,206,000
+3.5%
235,973
+3.8%
3.79%
-1.6%
Q1 2015$22,415,000
+9.8%
227,308
+3.2%
3.85%
+7.5%
Q4 2014$20,419,000
-2.4%
220,366
-0.9%
3.58%
-9.9%
Q3 2014$20,922,000
+36.6%
222,280
+31.4%
3.98%
+14.1%
Q2 2014$15,315,000
+7.4%
169,166
+0.8%
3.49%
+3.2%
Q1 2014$14,264,000
+8.4%
167,777
+2.5%
3.38%
+3.8%
Q4 2013$13,153,000
+6.0%
163,637
+1.2%
3.25%
-5.5%
Q3 2013$12,405,000
+9.7%
161,717
+1.1%
3.44%
+2.6%
Q2 2013$11,313,000159,9973.36%
Other shareholders
NOVARTIS A G shareholders Q2 2024
NameSharesValueWeighting ↓
MANAGED ASSET PORTFOLIOS, LLC 294,841$25,621,0005.62%
Mawer Investment Management Ltd. 5,990,387$520,565,0004.76%
SCHARF INVESTMENTS, LLC 1,177,939$102,363,0004.18%
PRENTISS SMITH & CO INC 69,603$6,048,0004.05%
EXENCIAL WEALTH ADVISORS, LLC 188,442$16,376,0003.52%
GARLAND CAPITAL MANAGEMENT INC 54,405$4,728,0003.38%
First Fiduciary Investment Counsel, Inc. 182,729$15,879,0003.36%
PUZO MICHAEL J 99,973$8,689,0003.27%
PROFESSIONAL ADVISORY SERVICES INC 198,174$17,221,0003.27%
WOODLEY FARRA MANION PORTFOLIO MANAGEMENT INC 369,442$32,105,0003.26%
View complete list of NOVARTIS A G shareholders